- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Allergy
Volume 2012 (2012), Article ID 321949, 5 pages
Can We Find Better Bronchodilators to Relieve Asthma Symptoms?
Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, 650 W 168th Street, New York, NY 10032, USA
Received 26 July 2012; Accepted 5 September 2012
Academic Editor: Yassine Amrani
Copyright © 2012 Elizabeth A. Townsend et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- D. Spina, “PDE4 inhibitors: current status,” British Journal of Pharmacology, vol. 155, no. 3, pp. 308–315, 2008.
- C. Schudt, A. Hatzelmann, R. Beume, and H. Tenor, “Phosphodiesterase inhibitors: history of pharmacology,” Handbook of Experimental Pharmacology, vol. 204, pp. 1–46, 2011.
- C. K. Billington, O. O. Ojo, R. B. Penn, and S. Ito, “cAMP regulation of airway smooth muscle function,” Pulmonary Pharmacology & Therapeutics. In press.
- C. P. Page and D. Spina, “Selective PDE inhibitors as novel treatments for respiratory diseases,” Current Opinion in Pharmacology, vol. 12, no. 3, pp. 275–286, 2012.
- M. A. Giembycz, “Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors,” Current Opinion in Pharmacology, vol. 5, no. 3, pp. 238–244, 2005.
- M. A. Giembycz and S. K. Field, “Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD,” Drug Design, Development and Therapy, vol. 4, pp. 147–158, 2010.
- N. J. Gross, M. A. Giembycz, and S. I. Rennard, “Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitor,” COPD, vol. 7, no. 2, pp. 141–153, 2010.
- L. M. Fabbri, P. M. Calverley, J. L. Izquierdo-Alonso et al., “Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials,” The Lancet, vol. 374, no. 9691, pp. 695–703, 2009.
- T. T. Kung, Y. Crawley, B. Luo, S. Young, W. Kreutner, and R. W. Chapman, “Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: Involvement of endogenously released corticosterone and catecholamines,” British Journal of Pharmacology, vol. 130, no. 2, pp. 457–463, 2000.
- A. Kanehiro, T. Ikemura, M. J. Mäkelä et al., “Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 1, pp. 173–184, 2001.
- P. L. Harbinson, D. MacLeod, R. Hawksworth et al., “The effect of a novel orally active selective PDE4 isoenzyme inhibitor (CDP840) on allergen-induced responses in asthmatic subjects,” European Respiratory Journal, vol. 10, no. 5, pp. 1008–1014, 1997.
- E. Van Schalkwyk, K. Strydom, Z. Williams et al., “Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions,” Journal of Allergy and Clinical Immunology, vol. 116, no. 2, pp. 292–298, 2005.
- S. Lu, N. Liu, S. B. Dass, T. F. Reiss, and B. A. Knorr, “Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma,” Respiratory Medicine, vol. 103, no. 3, pp. 342–347, 2009.
- D. Singh, F. Petavy, A. J. Macdonald, A. L. Lazaar, and B. J. O'Connor, “The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma,” Respiratory Research, vol. 11, article 26, 2010.
- Y. N. Clement, “Herbal self-medication at primary health care facilities in Trinidad,” Journal of Alternative and Complementary Medicine, vol. 15, no. 1, pp. 6–7, 2009.
- J. O. Rivera, H. W. Hughes, and A. G. Stuart, “Herbals and asthma: usage patterns among a border population,” Annals of Pharmacotherapy, vol. 38, no. 2, pp. 220–225, 2004.
- B. B. Singh, R. Khorsan, S. P. Vinjamury, C. Der-Martirosian, A. Kizhakkeveettil, and T. M. Anderson, “Herbal treatments of asthma: a systematic review,” Journal of Asthma, vol. 44, no. 9, pp. 685–698, 2007.
- T. P. Ng, M. L. Wong, C. Y. Hong, K. T. C. Koh, and L. G. Goh, “The use of complementary and alternative medicine by asthma patients,” QJM, vol. 96, no. 10, pp. 747–754, 2003.
- L. Bielory, “The science of complementary and alternative medicine: the plural of anecdote is not evidence,” Annals of Allergy, Asthma and Immunology, vol. 93, no. 2, pp. S1–S4, 2004.
- P. J. Busse, B. Schofield, N. Birmingham et al., “The traditional Chinese herbal formula ASHMI inhibits allergic lung inflammation in antigen-sensitized and antigen-challenged aged mice,” Annals of Allergy, Asthma and Immunology, vol. 104, no. 3, pp. 236–246, 2010.
- K. Kelly-Pieper, S. P. Patil, P. Busse et al., “Safety and tolerability of an antiasthma herbal formula (ashmi™) in adult subjects with asthma: a randomized, double-blinded, placebo-controlled, dose-escalation phase 1 study,” Journal of Alternative and Complementary Medicine, vol. 15, no. 7, pp. 735–743, 2009.
- T. Zhang, K. Srivastava, M. C. Wen et al., “Pharmacology and immunological actions of a herbal medicine ASHMI on allergic asthma,” Phytotherapy Research, vol. 24, no. 7, pp. 1047–1055, 2010.
- M. C. Wen, C. H. Wei, Z. Q. Hu et al., “Efficacy and tolerability of antiasthma herbal medicine intervention in adult patients with moderate-severe allergic asthma,” Journal of Allergy and Clinical Immunology, vol. 116, no. 3, pp. 517–524, 2005.
- K. Srivastava, T. Zhang, N. Yang, H. Sampson, and X. M. Li, “Anti-asthma simplified herbal medicine intervention-induced long-lasting tolerance to allergen exposure in an asthma model is interferon-γ, but not transforming growth factor-β dependent,” Clinical and Experimental Allergy, vol. 40, no. 11, pp. 1678–1688, 2010.
- Y. Sugimoto and S. Narumiya, “Prostaglandin E receptors,” Journal of Biological Chemistry, vol. 282, no. 16, pp. 11613–11617, 2007.
- A. T. Nials, C. J. Vardey, L. H. Denyer et al., “AH13205, a selective prostanoid EP2-receptor agonist,” Cardiovascular Drug Reviews, vol. 11, no. 2, pp. 165–179, 1993.
- J. Buckley, M. A. Birrell, S. A. Maher, A. T. Nials, D. L. Clarke, and M. G. Belvisi, “EP4 receptor as a new target for bronchodilator therapy,” Thorax, vol. 66, no. 12, pp. 1029–1035, 2011.
- D. A. Deshpande, W. C. H. Wang, E. L. McIlmoyle et al., “Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction,” Nature Medicine, vol. 16, no. 11, pp. 1299–1304, 2010.
- S. S. An, W. C. Wang, C. J. Koziol-White, et al., “TAS2R activation promotes airway smooth muscle relaxation despite 2-adrenergic receptor tachyphylaxis,” American Journal of Physiology, vol. 303, no. 4, pp. L304–L311, 2012.
- K. S. Robinett, D. A. Deshpande, M. M. Malone, and S. B. Liggett, “Agonist-promoted homologous desensitization of human airway smooth muscle bitter taste receptors,” American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 5, pp. 1069–1074, 2011.
- C. H. Zhang, C. Chen, L. M. Lifshitz, K. E. Fogarty, M. S. Zhu, and R. ZhuGe, “Activation of BK channels may not be required for bitter tastant-induced bronchodilation,” Nature Medicine, vol. 18, no. 5, pp. 648–651, 2012.
- S. S. An, K. S. Robinett, D. A. Deshpande, W. C. Wang, and S. B. Liggett, “Reply to: activation of BK channels may not be required for bitter tastant-induced bronchodilation,” Nature Medicine, vol. 18, no. 5, pp. 650–651, 2012.
- S. Hirota, N. Trimble, E. Pertens, and L. J. Janssen, “Intracellular Cl- fluxes play a novel role in Ca2+ handling in airway smooth muscle,” American Journal of Physiology, vol. 290, no. 6, pp. L1146–L1153, 2006.
- R. Zhuge, R. Bao, K. E. Fogarty, and L. M. Lifshitz, “Ca2+ sparks act as potent regulators of excitation-contraction coupling in airway smooth muscle,” Journal of Biological Chemistry, vol. 285, no. 3, pp. 2203–2210, 2010.
- K. Mizuta, D. Xu, Y. Pan et al., “GABAA receptors are expressed and facilitate relaxation in airway smooth muscle,” American Journal of Physiology, vol. 294, no. 6, pp. L1206–L1216, 2008.
- P. D. Yim, G. Gallos, D. Xu, Y. Zhang, and C. W. Emala, “Novel expression of a functional glycine receptor chloride channel that attenuates contraction in airway smooth muscle,” FASEB Journal, vol. 25, no. 5, pp. 1706–1717, 2011.
- J. R. Rock, C. R. Futtner, and B. D. Harfe, “The transmembrane protein TMEM16A is required for normal development of the murine trachea,” Developmental Biology, vol. 321, no. 1, pp. 141–149, 2008.
- F. Huang, J. R. Rock, B. D. Harfe et al., “Studies on expression and function of the TMEM16A calcium-activated chloride channel,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 50, pp. 21413–21418, 2009.
- C. Duran, Z. Qu, A. O. Osunkoya, Y. Cui, and H. C. Hartzell, “ANOs 3–7 in the anoctamin/Tmem16 Cl- channel family are intracellular proteins,” American Journal of Physiology, vol. 302, no. 3, pp. C482–C493, 2012.
- G. Gallos, P. Yim, S. Chang, et al., “Targeting the restricted alpha-subunit repertoire of airway smooth muscle GABAA receptors augments airway smooth muscle relaxation,” American Journal of Physiology, vol. 302, no. 2, pp. L248–L256, 2012.
- R. Pizov, R. H. Brown, Y. S. Weiss et al., “Wheezing during induction of general anesthesia in patients with and without asthma: a randomized, blinded trial,” Anesthesiology, vol. 82, no. 5, pp. 1111–1116, 1995.
- N. R. Gleason, G. Gallos, Y. Zhang, and C. W. Emala, “The GABAA agonist muscimol attenuates induced airway constriction in guinea pigs in vivo,” Journal of Applied Physiology, vol. 106, no. 4, pp. 1257–1263, 2009.
- G. Gallos, N. R. Gleason, Y. Zhang et al., “Activation of endogenous GABAA channels on airway smooth muscle potentiates isoproterenol-mediated relaxation,” American Journal of Physiology, vol. 295, no. 6, pp. L1040–L1047, 2008.
- L. J. Janssen, “Airway smooth muscle electrophysiology in a state of flux?” American Journal of Physiology, vol. 302, no. 8, pp. 730–732, 2012.
- G. Gallos, P. Yim, and C. W. Emala, “Chloride in airway smooth muscle: the ignored anion no longer?” American Journal of Physiology, vol. 302, no. 8, pp. L733–L735, 2012.